Whither Prescription Drugs?

That prescription medications continue to make negative headlines is no longer news. The price of these drugs is chief among its ‘problems.’ Besides being one of the main culprits in the soaring health spending in many countries, prescription drugs many claim have led them to bankruptcy in countries such as the U.S.1 Yet, it is doubtful that we can jettison prescription medications just yet, if ever. Consider insomnia, for example, a very common condition in many countries in adulthood, over a third of adults having some degree of insomnia every year in the U.S for example, where also up to 6% may use a medication to facilitate sleep2. Insomnia, unsatisfactory sleep that affects daytime functioning2, characterized by any of problems falling and staying asleep, poor sleep quality, or early morning awakening, for examples, has key public health implications, higher morbidity, and mortality due to accidents, heart, and psychiatric disorders, for examples. It could also be a difficult condition to treat, often lasting over a month, then technically defined as chronic insomnia, to which old age, unemployment, being female, lower socioeconomic status and unemployment predispose some, as could medications such as oral contraceptive, SSRIs, beta-blockers, Ritalin, lamotrigine, and atorvastatin. That, therapeutic options for treating individuals with insomnia are legion regardless, prescription drugs, benzodiazepines and non-benzodiazepines alike for examples, still offer some of the best hope for these patients. Non-pharmacologic treatments such as cognitive behavior therapy (CBT) and relaxation therapy for instance also help, and some studies have examined the potential benefits of combining non-pharmacologic and pharmacologic treatments for insomnia3. A comparison of benzodiazepine with CBT vs. benzodiazepine alone revealed that the former only minimally improved sleep efficiency3. Additionally, nonpharmacologic therapy resulted in a net gain of 0.37 quality-adjusted life-years with $2,781 savings over a decade compared with pharmacologic treatment or none at all3. Even with pharmacological agents, questions regarding the potential costs escalation with the abuse of benzodiazepines, which are much cheaper than non-benzodiazepines, although the potential for abusing the latter is much less.  Kindly click here to buy now via PayPal with your Credit Card or PayPal Account.